Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides
- PMID: 2218531
- DOI: 10.1126/science.2218531
Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides
Abstract
The amyloid beta protein is deposited in the brains of patients with Alzheimer's disease but its pathogenic role is unknown. In culture, the amyloid beta protein was neurotrophic to undifferentiated hippocampal neurons at low concentrations and neurotoxic to mature neurons at higher concentrations. In differentiated neurons, amyloid beta protein caused dendritic and axonal retraction followed by neuronal death. A portion of the amyloid beta protein (amino acids 25 to 35) mediated both the trophic and toxic effects and was homologous to the tachykinin neuropeptide family. The effects of the amyloid beta protein were mimicked by tachykinin antagonists and completely reversed by specific tachykinin agonists. Thus, the amyloid beta protein could function as a neurotrophic factor for differentiating neurons, but at high concentrations in mature neurons, as in Alzheimer's disease, could cause neuronal degeneration.
Similar articles
-
Cellular MTT reduction distinguishes the mechanism of action of beta-amyloid from that of tachykinin receptor peptides.Neuropeptides. 1996 Apr;30(2):125-32. doi: 10.1016/s0143-4179(96)90079-7. Neuropeptides. 1996. PMID: 8771554
-
Amyloid beta protein enhances the survival of hippocampal neurons in vitro.Science. 1989 Mar 17;243(4897):1488-90. doi: 10.1126/science.2928783. Science. 1989. PMID: 2928783
-
Inhibitors of free radical formation fail to attenuate direct beta-amyloid25-35 peptide-mediated neurotoxicity in rat hippocampal cultures.J Neurosci Res. 1994 Nov 1;39(4):494-505. doi: 10.1002/jnr.490390416. J Neurosci Res. 1994. PMID: 7533847
-
Amyloid beta-peptide: biphasic dose responses.Crit Rev Toxicol. 2001 Jul;31(4-5):605-6. doi: 10.1080/20014091111857. Crit Rev Toxicol. 2001. PMID: 11504184 Review.
-
Amyloid beta peptide membrane perturbation is the basis for its biological effects.Neurochem Res. 1999 Dec;24(12):1621-30. doi: 10.1023/a:1021172620295. Neurochem Res. 1999. PMID: 10591414 Review.
Cited by
-
Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease.Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):10998-1002. doi: 10.1073/pnas.88.24.10998. Proc Natl Acad Sci U S A. 1991. PMID: 1837142 Free PMC article.
-
Homology of the amyloid beta protein precursor in monkey and human supports a primate model for beta amyloidosis in Alzheimer's disease.Am J Pathol. 1991 Jun;138(6):1423-35. Am J Pathol. 1991. PMID: 1905108 Free PMC article.
-
Phosphorylation of actin-depolymerizing factor/cofilin by LIM-kinase mediates amyloid beta-induced degeneration: a potential mechanism of neuronal dystrophy in Alzheimer's disease.J Neurosci. 2006 Jun 14;26(24):6533-42. doi: 10.1523/JNEUROSCI.5567-05.2006. J Neurosci. 2006. PMID: 16775141 Free PMC article.
-
Administration of aggregated beta-amyloid peptide (25-35) induces changes in long-term potentiation in the hippocampus in vivo.Neurosci Behav Physiol. 2003 Feb;33(2):95-8. doi: 10.1023/a:1021761310435. Neurosci Behav Physiol. 2003. PMID: 12669778
-
Pro-domain removal in ASP-2 and the cleavage of the amyloid precursor are influenced by pH.BMC Biochem. 2002 Aug 31;3:25. doi: 10.1186/1471-2091-3-25. BMC Biochem. 2002. PMID: 12204094 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases